Morepen Double Down on Rx Innovation

Morepen Laboratories is pleased to announce the launch of four new products-Ticapen, UdoFix, LycoMore, Acifix in the month of April 2025 to cater the domestic market in addition to Empamore launched last month continuing its commitment to offer innovative latest products marking an another milestone reinforcing the doctor and patient trust. These new launches reflect our unwavering focus on research-led innovation, clinical excellence, and affordable healthcare access, addressing critical needs in cardiology, hepatology, nutrition, and diabetology.

This strategic expansion reinforces Morepen's commitment to scaling its finished dosages business while continuing to invest in cutting-edge R&D that powers a robust pipeline of differentiated, highquality medicines. Importantly, all APIs used in these products are manufactured in-house by Morepen at its world-class, USFDA-approved plants, ensuring consistent quality and supply chain control.

As India's #1 exporter of APIs for six globally used molecules-Loratadine, Montelukast, Desloratadine, Atorvastatin, Rosuvastatin, and Fexofenadine-Morepen has a presence in 82 countries, backed by an annual API manufacturing capacity of 144 metric tons. Its integrated capabilities across the pharmaceutical value chain give it a unique competitive edge in both regulated and emerging markets like the US, Europe, Japan, China, and Russia.

With a current formulation business size of approximately ₹325 crore, the company is now accelerating toward a ₹1,000 crore target over the next five years-driven by deeper market penetration, an expanded field force, and a growing portfolio of cost-efficient, globally compliant therapies.

With these additions and a focus on in-house R&D, API strength, and clinical partnerships, Morepen continues to lead with purpose-making medicines that matter, and making healthcare more accessible, affordable, and effective for millions of lives.

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 54.43 as compared to the previous close of Rs. 54.53. The total number of shares traded during the day was 661201 in over 3283 trades.

The stock hit an intraday high of Rs. 55.57 and intraday low of 52.90. The net turnover during the day was Rs. 35901622.00.

Source : Equity Bulls

Keywords

MorepenLaboratories INE083A01026 Pharmaceuticals 4Products Launch